Determinants of 15-year outcome with 1,119 standard Carpentier-Edwards porcine valves.

[1]  P E Oyer,et al.  Twenty-year clinical experience with porcine bioprostheses. , 1996, The Annals of thoracic surgery.

[2]  W. Jamieson,et al.  Carpentier-Edwards standard porcine bioprosthesis: clinical performance to seventeen years. , 1995, The Annals of thoracic surgery.

[3]  W. Angell,et al.  Bioprosthetic valve longevity in the elderly: an 18-year longitudinal study. , 1995, The Annals of thoracic surgery.

[4]  W. Jamieson,et al.  Porcine bioprostheses in the elderly: clinical performance by age groups and valve positions. , 1995, The Annals of thoracic surgery.

[5]  R. S. Mitchell,et al.  Durability of the Hancock MO bioprosthesis compared with standard aortic valve bioprostheses. , 1995, The Annals of thoracic surgery.

[6]  G. Thiene,et al.  Porcine valve durability: a comparison between Hancock standard and Hancock II bioprostheses. , 1995, The Annals of thoracic surgery.

[7]  J. Monro,et al.  Biological valves beyond fifteen years: the Wessex experience. , 1995, The Annals of thoracic surgery.

[8]  D. Glower,et al.  813-3 Results of Valve Replacement with Mechanical versus Biological Prostheses in Patients on Chronic Renal Dialysis , 1995 .

[9]  A Starr,et al.  Actuarial versus actual risk of porcine structural valve deterioration. , 1994, The Journal of thoracic and cardiovascular surgery.

[10]  W D White,et al.  Determinants of reoperation after 960 valve replacements with Carpentier-Edwards prostheses. , 1994, The Journal of thoracic and cardiovascular surgery.

[11]  G F Tyers,et al.  The Carpentier-Edwards standard porcine bioprosthesis. A first-generation tissue valve with excellent long-term clinical performance. , 1990, The Journal of thoracic and cardiovascular surgery.

[12]  L. Cohn,et al.  Fifteen‐Year Experience with 1678 Hancock Porcine Bioprosthetic Heart Valve Replacements , 1989, Annals of surgery.

[13]  G. Grunkemeier,et al.  The expected lifetime of porcine valves. , 1989, The Annals of thoracic surgery.

[14]  L. Cohn,et al.  Guidelines for reporting morbidity and mortality after cardiac valvular operations. , 1988, The Journal of thoracic and cardiovascular surgery.

[15]  J. Vandenbroucke,et al.  Bleeding Complications in Oral Anticoagulant Therapy , 1993 .

[16]  J. Vandenbroucke,et al.  Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. , 1993, Archives of internal medicine.